Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM Receives Positive EFSA Opinion for Methane-Reducing Feed Additive Bovaer?

11/19/2021 | 04:45am EST

Royal DSM announced that it has received a positive European Food Safety Agency (EFSA) opinion for the use of its novel methane-reducing feed additive for ruminants, Bovaer?, in the European Union. The EFSA opinion confirms that the feed additive reduces enteric methane emissions from dairy cows and is safe for the animal and the consumer. This opinion progresses the application to the final stage of approval from the European Commission Standing Committee on Plants, Animals, Food and Feed.


© S&P Capital IQ 2021
All news about ROYAL DSM N.V.
2021ROYAL DSM N : DSM completes the acquisition of Vestkorn Milling
PU
2021Koninklijke DSM N.V. completed the acquisition of Vestkorn Milling AS.
CI
2021ROYAL DSM N : DSM to acquire Vestkorn Milling to accelerate growth in plant-based proteins
PU
2021DSM Expands into Plant-Based Protein Products Via $74 Million Vestkorn Purchase
MT
2021Koninklijke DSM N.V. signed an agreement to acquire Vestkorn Milling As for an enterpri..
CI
2021EU Regulator Approves DSM's Methane-Reducing Feed Additive For Ruminants
MT
2021Royal DSM Receives Positive EFSA Opinion for Methane-Reducing Feed Additive Bovaer?
CI
2021ROYAL DSM N : DSM receives positive EFSA opinion for methane-reducing feed additive Bovaer..
PU
2021DSM to Build Large-scale Production Plant for Bovaer Feed Additive in Scotland
MT
2021DSM plans new production site for Bovaer® in Dalry, Scotland
PU
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2021 9 058 M 10 339 M 10 339 M
Net income 2021 1 396 M 1 594 M 1 594 M
Net Debt 2021 1 220 M 1 393 M 1 393 M
P/E ratio 2021 21,5x
Yield 2021 1,44%
Capitalization 30 065 M 34 341 M 34 316 M
EV / Sales 2021 3,45x
EV / Sales 2022 3,25x
Nbr of Employees 21 173
Free-Float -
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 176,30 €
Average target price 194,08 €
Spread / Average Target 10,1%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.-10.96%34 341
BASF SE10.25%71 454
SHIN-ETSU CHEMICAL CO., LTD-2.61%70 780
DUPONT DE NEMOURS, INC.5.19%44 023
PIDILITE INDUSTRIES LIMITED9.69%18 524
EVONIK INDUSTRIES AG1.37%15 361